Glu106 targeted inhibitors of ORAI1 as potential Ca²⁺ release-activated Ca²⁺ (CRAC) channel blockers – molecular modeling and docking studies

References

• McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205–19.
   PubMed Web of Science ®Google Scholar
• Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 2002;4:S265–72.
   PubMedGoogle Scholar
• Catrina AI, Joshua V, Klareskog L, Malmstrom V. Mechanisms involved in triggering rheumatoid arthritis. Immunol Rev 2016;269:162–74.
   PubMed Web of Science ®Google Scholar
• Chopra A, Abdel-Nasser A. Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract Res Clin Rheumatol 2008;22:583–604.
   PubMed Web of Science ®Google Scholar
• Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010;376:1094–108.
   PubMed Web of Science ®Google Scholar
• Beeton C, Wulff H, Standifer NE, et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci USA 2006;103:17414–19.
   PubMed Web of Science ®Google Scholar
• Clare JJ. Targeting ion channels for drug discovery. Discov Med 2010;9:253–60.
   PubMed Web of Science ®Google Scholar
• Bagal SK, Brown AD, Cox PJ, et al. Ion channels as therapeutic targets: a drug discovery perspective. J Med Chem 2013;56:593–624.
   PubMed Web of Science ®Google Scholar
• Gerlach AC, Antonio BM. Validation of ion channel targets. Channels (Austin) 2015;9:376–9.
   PubMed Web of Science ®Google Scholar
• Arcangeli A, Becchetti A. Novel perspectives in cancer therapy: targeting ion channels. Drug Resist Updat 2015;2122:11–19.
   Web of Science ®Google Scholar
• Bagal SK, Marron BE, Owen RM, et al. Voltage gated sodium channels as drug discovery targets. Channels (Austin) 2015;9:360–6.
   PubMed Web of Science ®Google Scholar
• Parekh AB. Store-operated CRAC channels: function in health and disease. Nat Rev Drug Discov 2010;9:399–410.
   PubMed Web of Science ®Google Scholar
• Feske S. CRAC channelopathies. Pflugers Arch. 2010;460:417–35.
   PubMed Web of Science ®Google Scholar
• Palty R, Isacoff EY. Cooperative Binding of Stromal Interaction Molecule 1 (STIM1) to the N and C Termini of Calcium Release-activated Calcium Modulator 1 (Orai1). J Biol Chem 2015;291:334–41.
   PubMed Web of Science ®Google Scholar
• Hou X, Pedi L, Diver MM, Long SB. Crystal structure of the calcium release-activated calcium channel Orai. Science 2012;338:1308–13.
   PubMed Web of Science ®Google Scholar
• Prakriya M. The molecular physiology of CRAC channels. Immunol Rev 2009;231:88–98.
   PubMed Web of Science ®Google Scholar
• Prakriya M. Store-operated Orai channels: structure and function. Curr Top Membr 2013;71:1–32.
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Feske S. Physiological and pathophysiological functions of SOCE in the immune system. Front Biosci (Elite Ed) 2012;4:2253–68.
   PubMedGoogle Scholar
• Feske S. Immunodeficiency due to defects in store-operated calcium entry. Ann NY Acad Sci 2011;1238:74–90.
   PubMed Web of Science ®Google Scholar
• Yen JH, Chang CM, Hsu YW, et al. A polymorphism of ORAI1 rs7135617, is associated with susceptibility to rheumatoid arthritis. Mediat Inflamm 2014;2014:834831
   PubMed Web of Science ®Google Scholar
• Liu S, Watanabe S, Shudou M, et al. Upregulation of store-operated Ca(2+) entry in the naïve CD4(+) T cells with aberrant cytokine releasing in active rheumatoid arthritis. . Immunol Cell Biol 2014;92:752–60.
   PubMed Web of Science ®Google Scholar
• Picard C, McCarl CA, Papolos A, et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med 2009;360:1971–80.
   PubMed Web of Science ®Google Scholar
• Feske S, Picard C, Fischer A. Immunodeficiency due to mutations in ORAI1 and STIM1. Clin Immunol 2010;135:169–82.
   PubMed Web of Science ®Google Scholar
• Jairaman A, Prakriya M. Molecular pharmacology of store-operated CRAC channels. Channels (Austin) 2013;7:402–14.
   PubMed Web of Science ®Google Scholar
• Derler I, Schindl R, Fritsch R, et al. The action of selective CRAC channel blockers is affected by the Orai pore geometry. Cell Calcium 2013;53:139–51.
   PubMed Web of Science ®Google Scholar
• Esteve C, Gonzalez J, Gual S, et al. Discovery of 7-azaindole derivatives as potent Orai inhibitors showing efficacy in a preclinical model of asthma. Bioorg Med Chem Lett 2015;25:1217–22.
   PubMed Web of Science ®Google Scholar
• Zhang HZ, Xu XL, Chen HY, et al. Discovery and structural optimization of 1-phenyl-3-(1-phenylethyl)urea derivatives as novel inhibitors of CRAC channel. Acta Pharmacol Sin 2015;36:1137–44.
   PubMed Web of Science ®Google Scholar
• Roy A, Kucukural A, Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 2010;5:725–38.
   PubMed Web of Science ®Google Scholar
• Laskowski RA, Rullmannn JA, MacArthur MW, et al. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 1996;8:477–86.
   PubMed Web of Science ®Google Scholar
• Berjanskii M, Liang Y, Zhou J, et al. PROSESS: a protein structure evaluation suite and server. Nucleic Acids Res 2010;38:W633–40.
   Google Scholar
• Selvaraj C, Sivakamavalli J, Vaseeharan B, et al. Structural elucidation of SrtA enzyme in Enterococcus faecalis: an emphasis on screening of potential inhibitors against the biofilm formation. Mol BioSyst 2014;10:1775–89.
   PubMed Web of Science ®Google Scholar
• Desmond Molecular Dynamics System (Version 3.0). (2011). New York, NY: D. E. Shaw Research. Maestro-Desmond Interoperability Tools (Version 3.0). Schrödinger. (2011). New York, NY. Available at: http://www.deshawresearch.com.
   Google Scholar
• Rashid MH, Kuyucak S. Free energy simulations of binding of HsTx1 toxin to Kv1 potassium channels: the basis of Kv1.3/Kv1.1 selectivity. J Phys Chem B 2014;118:707–16.
   PubMed Web of Science ®Google Scholar
• Selvaraj C, Sivakamavalli J, Baskaralingam V, Singh SK. Virtual screening of LPXTG competitive SrtA inhibitors targeting signal transduction mechanism in Bacillus anthracis: a combined experimental and theoretical study. J Recept Signal Transduction Res 2014;34:221–32.
   PubMed Web of Science ®Google Scholar
• Selvaraj C, Priya RB, Lee JK, Singh SK. Mechanistic insights of SrtA–LPXTG blockers targeting the transpeptidase mechanism in Streptococcus mutans. RSC Adv 2015;5:100498–510.
   Web of Science ®Google Scholar
• Project E, Friedman R, Nachliel E, Gutman M. A molecular dynamics study of the effect of Ca2+ removal on calmodulin structure. Biophys J 2006;90:3842–50.
   PubMed Web of Science ®Google Scholar
• Selvaraj C, Singh P, Singh SK. Investigations on the Interactions of lambda phage-derived peptides against the SrtA mechanism in Bacillus anthracis. Appl Biochem Biotechnol 2014;4:1790–806.
   Web of Science ®Google Scholar
• Vijayalakshmi P, Selvaraj C, Singh SK, et al. Exploration of the binding of DNA binding ligands to Staphylococcal DNA through QM/MM docking and molecular dynamics simulation. J Biomol Struct Dyn 2013;31:561–71.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3–26.
   PubMed Web of Science ®Google Scholar
• Selvaraj C, Sivakamavalli J, Vaseeharan B, et al. Examine the characterization of biofilm formation and inhibition by targeting SrtA mechanism in Bacillus subtilis: a combined experimental and theoretical study. J Mol Model 2014;20:2364
   PubMed Web of Science ®Google Scholar
• Potts RO, Guy RH. A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharmaceut Res 1995;12:1628–33.
   PubMed Web of Science ®Google Scholar
• Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL. Cheminformatic models to predict binding affinities to human serum albumin. J Med Chem 2001;44:4370–8.
   PubMed Web of Science ®Google Scholar
• Cavalli A, Poluzzi E, De Ponti F, Recanatini M. Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers. J Med Chem 2002;45:3844–53.
   PubMed Web of Science ®Google Scholar
• Selvaraj C, Singh SK. Validation of potential inhibitors for SrtA against Bacillus anthracis by combined approach of ligand-based and molecular dynamics simulation. J Biomol Struct Dyn 2014;32:1333–49.
   PubMed Web of Science ®Google Scholar
• Sherman W, Beard HS, Farid R. Use of an induced fit receptor structure in virtual screening. Chem Biol Drug Des 2006;67:83–4.
   PubMed Web of Science ®Google Scholar
• Cavasotto CN, Abagyan RA. Protein flexibility in ligand docking and virtual screening to protein kinases. J Mol Biol 2004;337:209–25.
   PubMed Web of Science ®Google Scholar
• Park IH, Li C. Dynamic ligand-induced-fit simulation via enhanced conformational samplings and ensemble dockings: a surviving example. J Phys Chem B 2010;114:5144–53.
   PubMed Web of Science ®Google Scholar
• Lyne PD, Lamb ML, Saeh JC. Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. J Med Chem 2006;49:4805–8.
   PubMed Web of Science ®Google Scholar
• Mobley DL, Dill KA. Binding of small-molecule ligands to proteins: “what you see” is not always “what you get”. Structure 2009;17:489–98.
   PubMed Web of Science ®Google Scholar
• Du J, Dong H, Zhou HX. Gating mechanism of a P2X4 receptor developed from normal mode analysis and molecular dynamics simulations. Proc Natl Acad Sci USA 2012;109:4140–5.
   PubMed Web of Science ®Google Scholar
• Park CY, Hoover PJ, Mullins FM, et al. STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. Cell 2009;136:876–90.
   PubMed Web of Science ®Google Scholar
• Zheng H, Zhou MH, Hu C, et al. Differential roles of the C and N termini of Orai1 protein in interacting with stromal interaction molecule 1 (STIM1) for Ca2+ release-activated Ca2+ (CRAC) channel activation. J Biol Chem 2013;288:11263–72.
   PubMed Web of Science ®Google Scholar
• McNally BA, Somasundaram A, Jairaman A, et al. The C- and N-terminal STIM1 binding sites on Orai1 are required for both trapping and gating CRAC channels. J Physiol 2013;591:2833–50.
   PubMed Web of Science ®Google Scholar
• Shim AH, Tirado-Lee L, Prakriya M. Structural and functional mechanisms of CRAC channel regulation. J Mol Biol 2015;427:77–93.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ramachandran S, Oh-Hora M, et al. Pore architecture of the ORAI1 store-operated calcium channel. Proc Natl Acad Sci USA 2010;107:4896–901.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Srinivasan P, Razavi S, et al. Initial activation of STIM1, the regulator of store-operated calcium entry. Nat Struct Mol Biol 2013;20:973–81.
   PubMed Web of Science ®Google Scholar
• Deol SS, Bond PJ, Domene C, Sansom MS. Lipid-protein interactions of integral membrane proteins: a comparative simulation study. Biophys J 2004;87:3737–49.
   PubMed Web of Science ®Google Scholar
• Ash WL, Zlomislic MR, Oloo EO, Tieleman DP. Computer simulations of membrane proteins. Biochim Biophys Acta 2004;1666:158–89.
   PubMed Web of Science ®Google Scholar
• Komeiji Y, Ueno Y, Uebayasi M. Molecular dynamics simulations revealed Ca(2+)-dependent conformational change of Calmodulin. FEBS Lett 2002;521:133–9.
   PubMed Web of Science ®Google Scholar